Altimmune (ALT) Competitors

Altimmune (NASDAQ:ALT) and Schrödinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Do analysts rate ALT or SDGR?

Altimmune currently has a consensus price target of $20.83, suggesting a potential upside of 222.65%. Schrödinger has a consensus price target of $32.11, suggesting a potential upside of 40.96%. Given Altimmune's stronger consensus rating and higher probable upside, analysts clearly believe Altimmune is more favorable than Schrödinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Altimmune	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.00
Schrödinger	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80

Which has better earnings & valuation, ALT or SDGR?

Schrödinger has higher revenue and earnings than Altimmune. Schrödinger is trading at a lower price-to-earnings ratio than Altimmune, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Altimmune	$430K	1,067.96	-$88.45M	-$1.55	-4.17
Schrödinger	$216.67M	7.66	$40.72M	-$2.34	-9.74

Does the media favor ALT or SDGR?

In the previous week, Altimmune had 3 more articles in the media than Schrödinger. MarketBeat recorded 7 mentions for Altimmune and 4 mentions for Schrödinger. Schrödinger's average media sentiment score of 0.68 beat Altimmune's score of 0.65 indicating that Schrödinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Altimmune	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrödinger	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, ALT or SDGR?

Altimmune has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, Schrödinger has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of ALT or SDGR?

78.1% of Altimmune shares are owned by institutional investors. Comparatively, 79.1% of Schrödinger shares are owned by institutional investors. 4.1% of Altimmune shares are owned by insiders. Comparatively, 8.6% of Schrödinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community prefer ALT or SDGR?

Altimmune received 5 more outperform votes than Schrödinger when rated by MarketBeat users. Likewise, 73.75% of users gave Altimmune an outperform vote while only 57.45% of users gave Schrödinger an outperform vote.

Company	Underperform	Outperform
Altimmune	Outperform Votes 59 73.75%	Underperform Votes 21 26.25%
Schrödinger	Outperform Votes 54 57.45%	Underperform Votes 40 42.55%

Is ALT or SDGR more profitable?

Schrödinger has a net margin of -91.84% compared to Altimmune's net margin of -199,076.92%. Schrödinger's return on equity of -35.77% beat Altimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Altimmune	-199,076.92%	-55.81%	-50.60%
Schrödinger	-91.84%	-35.77%	-24.51%

Summary

Schrödinger beats Altimmune on 9 of the 17 factors compared between the two stocks.